Shopping Cart
- Remove All
- Your shopping cart is currently empty
Maytansinoid B, an ADC cytotoxin, conjugates with antibodies to create antibody-drug conjugates (ADCs). This antimitotic agent binds to tubulin, inhibiting microtubule assembly, and induces G2/M arrest in the cell cycle, leading to apoptosis [1] [2].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | 8-10 weeks | |
50 mg | Inquiry | 8-10 weeks |
Description | Maytansinoid B, an ADC cytotoxin, conjugates with antibodies to create antibody-drug conjugates (ADCs). This antimitotic agent binds to tubulin, inhibiting microtubule assembly, and induces G2/M arrest in the cell cycle, leading to apoptosis [1] [2]. |
In vitro | Maytansinoid displays cytotoxic activity in the range of 10-90 pM against several tumor cell lines, including lymphoma [1]. When conjugated with an anti-CD9 antibody, it forms SAR3419, which targets B-cell malignancies [1]. |
Molecular Weight | 735.26 |
Formula | C36H51ClN4O10 |
Cas No. | 1628543-40-7 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.